Max Robotics — Global Service Robot Directory + US Certification

About

Ardan M. Saguner is a leading figure in cardiac electrophysiology, with a primary focus on ventricular arrhythmias and sudden cardiac death. His research has significantly advanced the understanding and treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC), where his work on risk stratification and genetic mechanisms has shaped clinical guidelines. Saguner is also at the forefront of an emerging, non-invasive therapy: cardiac radioablation for ventricular tachycardia. He is a key investigator in the landmark RAVENTA trial, and his 2022 paper on treatment planning for this technique, which established a crucial multi-center benchmarking protocol, has already garnered 12 citations, reflecting its immediate impact on standardizing this novel approach. Beyond his work on radioablation, his broader contributions to the field are underscored by numerous highly-cited studies on the natural history and management of ARVC, making him a pivotal voice in translating complex electrophysiological insights into tangible, life-saving treatments for patients with the most challenging cardiac conditions.